Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex
about
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsAdvanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cellsThe expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculasMolecular Pathways Regulating Macrovascular Pathology and Vascular Smooth Muscle Cells Phenotype in Type 2 DiabetesRole of advanced glycation end products in cellular signalingAdvanced glycation end products and diabetic complicationsKlotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depressionAdvanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathyA multicellular signal transduction network of AGE/RAGE signalingDifferential effects of glycation on protein aggregation and amyloid formation.Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasisMolecular mechanisms of diabetic vascular complicationsControlling the receptor for advanced glycation end-products to conquer diabetic vascular complicationsGalectin-3 is a new MerTK-specific eat-me signal.Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice.Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategiesEvidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Regulation of RAGE for attenuating progression of diabetic vascular complications.Galectin-3 surface expression on human adult chondrocytes: a potential substrate for collagenase-3.Galectin-3 expression in human atherosclerotic lesions.Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEsPharmacodynamic interaction of fenugreek, insulin and glimepiride on sero-biochemical parameters in diabetic Sprague-Dawley rats.The oxidase activity of vascular adhesion protein-1 (VAP-1) is essential for function.Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity.Dietary hyperglycemia, glycemic index and metabolic retinal diseases.Galectin-3 in cardiac remodeling and heart failure.Phagocyte dysfunction, tissue aging and degeneration.Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma.Mechanisms of distal axonal degeneration in peripheral neuropathies.Altered Expression of NF- κ B and SP1 after Exposure to Advanced Glycation End-Products and Effects of Neurotrophic Factors in AGEs Exposed Rat Retinas.Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epitheliumBelow the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver diseaseFood Processing: The Influence of the Maillard Reaction on Immunogenicity and Allergenicity of Food Proteins.Advanced glycation end products (AGEs) activate mast cells.
P2860
Q24530074-81C87826-E161-402C-877C-B5DC79DE7667Q24563997-464E0BA2-F2F4-420C-AA06-A76A42367EEEQ24602544-643B1DC6-336B-4C68-8BD9-12EE7413FB77Q26782445-DB65BE93-26D6-4CD3-9E3E-B6DD7191E112Q27003423-B6DBCCEE-D106-4DC5-A427-61A14176288CQ27687501-B7DF7069-0E3B-4C43-A535-08087319D36CQ28079797-E3AA97BA-70C2-45BE-B5F7-9E2C34589389Q28366662-1D9D070B-3E2A-48F8-BA61-121881F45A1CQ28476732-019E9F35-1ED3-4387-BE8B-F75D8AA581A9Q28704994-2900EF06-0567-4F16-8601-7B237CA01C39Q30374807-089E9462-8E2C-4EEC-86EC-AD8A545B4A12Q32085442-B6A74701-A7B5-4BAF-B97A-38876E504425Q33558421-270C61EF-3245-41B2-95E7-4F760E5A614BQ33609776-469E3941-EFCE-4243-B42D-5D952213A88BQ33972695-7C85FA0B-C0BD-4500-9EEF-5F56AE89A8EFQ34603941-99413DA0-AFBD-4BCD-BFA0-3EC8686E097AQ34728267-EAE113B4-DDAA-4E5D-98B6-6197E342EDE2Q34987953-53820F66-EE9D-4EED-B410-D2A48BF8B01FQ35170154-A9789013-514D-4CBC-BBC2-7A1C9460CE13Q35494903-8A3EE542-65BF-4377-8193-784D8F667467Q35554146-8170A994-D080-4231-BFE0-7BBBBD8C5FF3Q35765442-A35B6A81-DD0C-4B5A-A094-D20D54EE5E81Q36357458-370A46A7-CC5B-48A7-8B38-B1C73FC90E0CQ36437790-17C046E0-9566-4C48-95B1-AB263AA862D5Q36641149-57D13666-B136-48BF-B107-D0B3876C370CQ37021621-4CD8DEEF-2C64-4CFD-B555-76593ACA2791Q37308593-D847B5F7-09F2-438C-A7AC-ABDD4BA5D181Q37431946-F771CA47-7969-48B3-A865-F6C7EA38B98DQ37635868-61B81D7D-0B3A-4069-AEC0-7E50C54F88EDQ37733102-B6FDB0BE-2268-4BE3-9F6F-EB5080BC70E9Q37738648-80540190-9E1A-40B6-819D-D9C80989CE94Q38113059-7F6490B5-5053-41B7-9CCE-76F7924A125DQ38174863-973B3839-14B4-4BF0-A0E6-C811D1B14091Q38330759-4CB47C4C-DF6B-4673-830A-65FE6C4B537BQ38863647-F7CFAD38-D303-4A88-B34B-D019A2290E18Q40477757-54F2BC55-EA95-4698-AC31-03F1855AF7FFQ40802125-AFE1BCDE-AC56-4A55-B813-C59A37850DF1Q41134548-206C24E0-EDFE-4224-980B-640A3BACFF3DQ41583979-678255FD-1A3B-410E-81B0-4A66F70E23A1Q41682122-441A52DB-CF9B-4F07-AF05-BA103F90C73D
P2860
Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex
description
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1995
@ast
scientific journal article
@en
vedecký článok (publikovaný 1995/09/01)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/09/01)
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована у вересні 1995
@uk
مقالة علمية (نشرت في سبتمبر 1995)
@ar
name
Identification of galectin-3 a ...... er of the AGE-receptor complex
@ast
Identification of galectin-3 a ...... er of the AGE-receptor complex
@en
Identification of galectin-3 a ...... er of the AGE-receptor complex
@nl
type
label
Identification of galectin-3 a ...... er of the AGE-receptor complex
@ast
Identification of galectin-3 a ...... er of the AGE-receptor complex
@en
Identification of galectin-3 a ...... er of the AGE-receptor complex
@nl
prefLabel
Identification of galectin-3 a ...... er of the AGE-receptor complex
@ast
Identification of galectin-3 a ...... er of the AGE-receptor complex
@en
Identification of galectin-3 a ...... er of the AGE-receptor complex
@nl
P2093
P2860
P3181
P1433
P1476
Identification of galectin-3 a ...... er of the AGE-receptor complex
@en
P2093
D. Wojciechowicz
H. Vlassara
P2860
P304
P3181
P407
P577
1995-09-01T00:00:00Z